Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanoma.

Front Med (Lausanne) · 2023 · PMC9899839 · PMID 36756176

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Although there is a variation in the selection criteria between the two studies making it hard to compare, we also observed that PFS variation among different age groups was highly significant when ICIs were not given as a first-line treatment.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.